Viz AAA vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Viz AAA if…
Choose Viz AAA if your institution needs to rapidly identify and prioritize suspected Abdominal Aortic Aneurysm (AAA) cases directly from CT angiography scans. This tool is ideal for emergency departments, radiology, and vascular surgery teams aiming to accelerate diagnosis, streamline care coordination, and improve treatment decisions for acute aortic pathologies.
View Viz AAA →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinicians require a non-invasive, point-of-care screening solution for early detection of low ejection fraction during routine physical exams. This tool is best suited for primary care, internal medicine, and cardiology practices looking to quickly identify patients at risk for heart failure using integrated digital stethoscope technology.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz AAA | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Enterprise (hospital/health system) | Unknown |
| Deployment | Cloud-based, integrates with PACS and EHR systems. | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA emphasizes seamless integration into existing hospital workflows, real-time alerts, and a HIPAA-compliant communication platform for multidisciplinary teams. Its mobile access to high-fidelity imaging further enhances usability within a complex care environment, facilitating broader care coordination beyond just detection.
Clinical Value
Viz AAABoth tools offer significant clinical value through FDA-cleared AI for critical conditions. However, Viz AAA is the 'first FDA-cleared AI-powered solution' for AAA detection and triage, directly accelerating diagnosis and care coordination for a time-sensitive, life-threatening condition. This focus on rapid intervention for acute cases gives it a slight edge in immediate critical clinical impact.
Pricing & Value
TieNeither tool provides public pricing tiers, making a direct comparison of value challenging. Both require direct contact for pricing information. While Viz AAA describes its subscription model based on algorithms and population size, this still lacks concrete figures to assess overall value against ELEFT's 'enterprise solution' pricing.
Enterprise Readiness
Viz AAABoth tools are FDA-cleared, HIPAA compliant, cloud-based, and part of larger platforms, indicating strong foundational readiness. Viz AAA explicitly highlights 'integration into existing hospital workflows' and a 'HIPAA-compliant communication platform for multidisciplinary teams,' which directly addresses the complex deployment and collaborative needs of enterprise healthcare systems.
Innovation
Viz AAABoth tools demonstrate innovation in their respective domains. Viz AAA is noted as the 'first FDA-cleared AI-powered solution' for AAA detection and triage from CT scans, marking a pioneering advancement in radiology and emergency care. While ELEFT's integration with digital stethoscopes for real-time low ejection fraction detection is also innovative, Viz AAA's 'first-in-class' status for a critical application gives it a slight lead in groundbreaking innovation.
Support & Docs
Viz AAAViz.ai offers a Knowledge Base, in-app support, email support, and notably, 24/7 urgent phone support with a guaranteed 15-minute callback for critical issues. This level of immediate, round-the-clock support for urgent clinical scenarios provides a stronger assurance of operational continuity compared to Eko Health's comprehensive but less explicitly urgent-focused support options.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz AAA | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | Viz AAA | Eko Low Ejection Fraction Tool (ELEFT) |
| Primary Function | AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. | AI algorithm to aid clinicians in the early detection of low ejection fraction during routine physical exams. |
| Company | Viz.ai | Eko Health |
| Target Condition/Detection | Suspected Abdominal Aortic Aneurysm (AAA) | Low ejection fraction (key indicator of heart failure) |
| Integration/Modality | From CT angiography scans, integrates into existing hospital workflows. | Integrates with FDA-cleared Eko digital stethoscopes, analyzes ECG and heart sound recordings. |
| Specialties | Emergency Medicine, Radiology, Vascular Surgery | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Viz AAA and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Viz AAA or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.